Antia I J, Smith C E, Wood A J, Aronson J K
University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, UK.
J Affect Disord. 1995 Apr 16;34(1):33-9. doi: 10.1016/0165-0327(94)00102-f.
Patients with manic depressive disorder (DSM-III-R bipolar disorder) have an abnormality of the Na+,K(+)-ATPase pumps in their lymphocytes: the pump numbers do not upregulate to stimulation with lithium and ethacrynate. We have now investigated the in vitro adaptive responses of lymphocyte Na+,K(+)-ATPase pumps in the first-degree unaffected relatives of patients with a clear history of manic depressive disorder. The lymphocytes of the healthy relatives upregulated their Na+,K(+)-ATPase pumps normally, suggesting that the abnormal response that we have previously observed in patients with the disorder reflects a complex relation between the biochemical phenotype and the development of clinical symptoms.